AI in Life Sciences
-
Can AI Replace Medical Information Specialists? Opportunities, Risks, and Reality
Read more: Can AI Replace Medical Information Specialists? Opportunities, Risks, and RealityAI in Medical Information is transforming how pharmaceutical companies respond to healthcare professionals, patients, and caregivers. From intelligent scientific search to AI-generated responses, new technologies promise greater efficiency and lower operational costs. But this raises an important question: Can AI replace medical information specialists, or will it simply change how they work? The answer is…
-
AI-Designed Antibiotics: What Gonorrhoea and MRSA Breakthroughs Mean for Pharma R&D
Read more: AI-Designed Antibiotics: What Gonorrhoea and MRSA Breakthroughs Mean for Pharma R&DAI-Designed Antibiotics are no longer science fiction — they are here. In a landmark MIT study published in Cell, generative AI created two novel compounds capable of killing drug-resistant gonorrhoea and MRSA in laboratory and animal tests. This achievement not only demonstrates the power of AI in antimicrobial research but also signals a potential turning…
-
The EU AI Act and Pharma Compliance: What Life Sciences Companies Need to Know
Read more: The EU AI Act and Pharma Compliance: What Life Sciences Companies Need to KnowThe EU AI Act is reshaping how pharmaceutical and life sciences companies develop and deploy AI — from clinical trials to diagnostics. As the world’s first comprehensive AI regulation, it introduces strict rules around risk classification, human oversight, and audit trails. If your company is building AI-powered tools or seeking approval in the EU and…
-
FDA AI Food Safety: How ELSA is Changing Import Oversight
Read more: FDA AI Food Safety: How ELSA is Changing Import OversightSummary:FDA ELSA AI food safety efforts mark a turning point in how the agency screens food imports, using machine learning to flag high-risk shipments. In June 2025, the FDA announced the agency-wide launch of a powerful new AI tool named ELSA (Enhanced Learning and Surveillance Algorithm). Designed to improve how the FDA screens imported foods,…
-
FDA’s 2025 Draft Guidance on AI in Drug Development: What It Means for Biopharma
Read more: FDA’s 2025 Draft Guidance on AI in Drug Development: What It Means for BiopharmaAI in drug development is rapidly transforming how therapies are discovered, tested, and submitted for approval—but until now, regulatory guidance has struggled to keep up. That changed in January 2025, when the U.S. Food and Drug Administration (FDA) published its first-ever draft guidance focused on the use of AI to support regulatory decision-making in the…
AI Innovations
Explore how AI is revolutionizing drug discovery, clinical trials, and healthcare analytics.